Q1 2026 Surgical Science Sweden AB Earnings Call Transcript
Key Points
- Despite a reported sales decline of 6%, the underlying business grew by 4% when adjusted for currency effects.
- Cash flow from operations was strong at SEK65 million, significantly better than the same quarter last year.
- Educational products saw a growth of 6% or 14% in local currencies, with EMEA revenue up over 80%.
- The UK posted one of its best quarters ever, with sales in pounds sterling exceeding the total for all of 2025.
- Ultrasound had a strong quarter, with increasing adoption across clinical settings, particularly in women's health.
- Reported sales were down 6% to SEK236 million, primarily due to currency headwinds.
- The Americas experienced a 10% decline in local currency sales, with purchasing decisions taking longer due to market hesitation.
- Chinese sales declined due to government support for locally operated companies, creating a headwind for the Simulator business.
- Robotics industry revenues were down 17%, with license revenue decreasing to SEK68 million from SEK84 million in the previous year.
- The memorandum of understanding with Intuitive did not result in a signed agreement, impacting license revenues negatively.
Welcome to Surgical Science Q1 report 2026 presentation. (Operator Instructions) Now, I will hand over to the speakers, CEO, Tom Englund; and CFO, Anna Ahlberg. Please go ahead.
Hi, everyone, and welcome to this earnings call for Surgical Science for the first quarter of 2026. My name is Tom Englund. I'm the CEO. And with me today, I have Anna Ahlberg, our CFO. So we'll start with a walkthrough of quarter one and the numbers, and then we'll open up for questions.
So quarter one is a quarter with two stories running in parallel. On the surface, reported sales are down 6% to SEK236 million. But once you strip out the currency headwind that we had and the dollar moved significantly against us, the underlying business grew by 4%. And if you look at cash flow, we generated SEK65 million from operations, which is a very strong number and significantly better than the same quarter last year. So the business itself is in good shape.
Adjusted EBIT came in at SEK28 million or 12%. That's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
